Hillenmeyer: Genomic data scale enables quant-style search focusing
Maureen Hillenmeyer · Discovering Life-Saving Drugs from Fungi! · Joe Lonsdale · Sep 24, 2021 · at 10:04
Maureen Hillenmeyer, founder and CEO of Hexagon Bio, describes how scaling genomic data improves computational predictive capability.
0:00 / 0:12exact quote · 12.0s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“As we're getting more genomes and more data it's kind of like the quant effect on wall street effect on wall street. We can start to really see which genomes are going to be useful and which ones are not and focus the search.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Maureen Hillenmeyer
Hillenmeyer: Academia's credit-based incentives drive competition and misalignment versus industry
“The currency in industry is, is money or financial, and the currency in academia is credit. And it just leads to interesting incentives. There's a lot of competition. People aren't kind of rowing the same direction all the time. You're trying to take credit ma…”
Hillenmeyer: Female investor representation in biotech is strong and growing
“I actually see a lot of women investors on the biotech side. I think less on the tech side, but I think the numbers are great and growing.”
Hillenmeyer: The antibacterial drug market is broken
“The antibacterial problem is different. Sadly, the market there is just It's broken. Companies know this, the government knows this.”
Hillenmeyer: Drug-resistant bacteria will hit as a massive wave
“The problem is this growing drug resistance in bacteria, they're just swapping these drug resistance genes left and right. It's really scary, and it, it'll, it'll be a massive wave that'll hit us. We just don't quite know when, and investors don't know when th…”